Status:
TERMINATED
Real-time Tumor Localization and Guidance for Radiotherapy Using Ultrasound (US) and Magnetic Resonance (MR)
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Conditions:
Tumor, Solid
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of this protocol is to evaluate the feasibility of acquiring simultaneous 4D ultrasound and 4D MRI scans. The imaging performance of the US and MRI scans will be characterized. T...
Detailed Description
The goal of radiotherapy treatment of cancer is to cure or locally control the disease while minimizing complications to healthy tissue. Given the complexity of tumor and normal tissue response to rad...
Eligibility Criteria
Inclusion
- Inclusion Criteria (Healthy Volunteers):
- Must be eighteen (18) years of age or older.
- Must be able to provide informed consent.
- Inclusion Criteria (Patients):
- Patients diagnosed with malignancies of the liver.
- Exclusion Criteria (All):
- Under the age of eighteen (18) years.
- BMI exceeds the size of the bore of the MRI scanner.
- Unable or unwilling to provide informed consent.
- Contraindications, as described in the volunteer consent form, to MR or US scanning such as but not limited to accidental or implanted ferrous metal and/or implanted devices whose function can be disturbed by the main magnetic field, gradient magnetic fields, or radiofrequency energy.
- Women who are pregnant, suspect they might be pregnant or breastfeeding.
Exclusion
Key Trial Info
Start Date :
September 14 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 4 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04095091
Start Date
September 14 2017
End Date
October 4 2019
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin, Madison
Madison, Wisconsin, United States, 53704